11.beta.-aryl-17, 17-spirothiolane-substituted steroids

Cook, C., Shetty, RS., Kepler, J., & Lee, DY. (2000). IPC No. U.S. 11.beta.-aryl-17, 17-spirothiolane-substituted steroids. (U.S. Patent No. 6043235).

Abstract

The invention is directed to 11.beta.-aryl-17,17-spirothiolanesubstituted steroid compounds of formula (I) exhibiting binding tothe progestin receptor. ##STR1## Also disclosed are methods ofusing and process of making the compounds.

Download/Explore

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Article

What's in a name? A data-driven method to identify optimal psychotherapy classifications to advance treatment research on co-occurring PTSD and substance use disorders
Article

Grandi Byen-supporting child growth and development through integrated, responsive parenting, nutrition and hygiene
Article

Effects of additional context information in prescription drug information sheets on comprehension and risk and efficacy perceptions
Article

What Is “socioeconomic position (SEP),” and how might it modify air pollution-health associations? Cohering findings, identifying challenges, and disentangling effects of SEP and race in US city settings